 BOCA RATON, Fla., Feb. 07, 2022 GLOBE NEWSWIRE -- First Wave BioPharma, Inc., NASDAQ:FWBI, First Wave BioPharma or the Company, a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal GI diseases, today announced that James Sapirstein, Chairman, President and CEO of First Wave BioPharma, will deliver a virtual presentation at the 2022 BIO CEO Investor Conference. The event is taking place February 14-17, 2022, at the New York Marriott Marquis as a hybrid conference that allows virtual and in-person participation. 